Jaspamycin (7-CN-7-C-Ino) is primarily utilized in the field of biomedical research due to its potent biological activity. It has shown significant promise as an antimicrobial agent, particularly in combating resistant strains of bacteria. Researchers are exploring its potential in developing new antibiotics to address the growing issue of antibiotic resistance. Additionally, it has been studied for its anticancer properties, with preliminary findings indicating its ability to inhibit the growth of certain cancer cell lines. This makes it a candidate for further investigation in cancer therapy. Its unique structure and mechanism of action also make it a valuable compound for studying cellular processes and developing novel therapeutic strategies.